Challenges in the treatment of depression with psychotic features.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biological Psychiatry

• Publication date

  2003-04-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0006-3223(02)01747-XPMID 12706954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How long should patients with psychotic depression stay on the antipsychotic medication?

  2003cited by this paper
• Label Trial of C-1073 ( Mifepristone ) for Psychotic Major Depression *

  2002cited by this paper
• Cortisol activity and cognitive changes in psychotic major depression.

  2001cited by this paper
• An Open Trial of Olanzapine in the Treatment of Patients with Psychotic Depression

  2001cited by this paper
• Rapid Reversal of Psychotic Depression Using Mifepristone

  2001cited by this paper
• A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

  2001cited by this paper
• Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

  2001cited by this paper
• Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.

  2000cited by this paper
• Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.

  2000cited by this paper
• Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

  2000cited by this paper
• Olanzapine in the treatment of psychotic depression

  1999cited by this paper
• Selective serotonin reuptake inhibitors and delusional depression.

  1999cited by this paper
• Neuropsychological deficits in psychotic versus nonpsychotic unipolar depression.

  1999cited by this paper
• Olanzapin in der Behandlung depressiver Störungen mit psychotischer Symptomatik

  1999cited by this paper
• [Olanzapine in the treatment of depressive disorders with psychotic symptoms].

  1999cited by this paper
• Olanzapine response in psychotic depression.

  1999cited by this paper
• Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.

  1999cited by this paper
• The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features.

  1999cited by this paper
• Candidate neuroanatomic substrates of ssychosis in old-aged depression

  1999cited by this paper
• Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia.

  1998cited by this paper
• Use of ECT for the inpatient treatment of recurrent major depression.

  1998cited by this paper
• The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT

  1998cited by this paper
• Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.

  1998cited by this paper
• Clinical predictors of acute response with quetiapine in psychotic mood disorders.

  1998cited by this paper
• DST studies in psychotic depression: a meta-analysis.

  1997cited by this paper
• Treatment of psychotic depression.

  1997cited by this paper
• Low use of neuroleptic drugs in the treatment of psychotic major depression.

  1997cited by this paper
• Management of psychotic, treatment-resistant depression.

  1996cited by this paper
• Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.

  1996cited by this paper
• Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.

  1996cited by this paper
• Fluvoxamine alone in the treatment of delusional depression.

  1996cited by this paper
• Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression.

  1996cited by this paper
• Importance of psychotic features to long-term course in major depressive disorder.

  1996cited by this paper
• Paroxetine as Antidepressant in Combined Antidepressant-neuroleptic Therapy in Delusional Depression: Observation of Clinical Use

  1995cited by this paper
• Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.

  1995cited by this paper
• Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

  1995cited by this paper
• Risperidone in the treatment of affective illness and obsessive-compulsive disorder.

  1995cited by this paper
• Risperidone in the treatment of affective illness and obsessive-compulsive disorder.

  1995cited by this paper
• Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.

  1995cited by this paper
• The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.

  1995cited by this paper
• Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

  1994cited by this paper
• Diagnosis and Treatment of Psychotic (Delusional) Depression

  1994cited by this paper
• The prognostic importance of delusions in depression: a 6-year prospective follow-up study.

  1994cited by this paper
• Severe Depressive Disorders

  1994cited by this paper
• Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.

  1993cited by this paper
• Ketoconazole administration in hypercortisolemic depression.

  1993cited by this paper
• Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

  1993cited by this paper
• Clozapine use in diffuse Lewy body disease.

  1993cited by this paper
• Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.

  1993cited by this paper
• Clozapine in the Treatment of Psychotic Refractory Depression

  1993cited by this paper
• Psychotic depression -- a newly recognized subtype

  1993cited by this paper
• The Pathophysiologic Significance of Hyperadrenocorticism: Antiglucocorticoid Strategies

  1993cited by this paper
• Predicting length of stay for patients with psychoses.

  1992cited by this paper
• Psychotic (delusional) depression: a meta-analysis of physical treatments.

  1992cited by this paper
• Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional Approach

  1992cited by this paper
• Clinical Management of Clozapine Patients in Relation to Efficacy and Side-Effects

  1992cited by this paper
• Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

  1992cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• Effect of clozapine on psychotic depression and parkinsonism.

  1991cited by this paper
• The validity of major depression with psychotic features based on a community study.

  1991cited by this paper
• Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea

  1991cited by this paper
• A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression.

  1991cited by this paper
• The endocrine effects of long-term treatment with mifepristone (RU 486).

  1991cited by this paper
• Distinguishing psychotic and non-psychotic melancholia.

  1991cited by this paper
• Electroconvulsive therapy in the treatment of depression: the impact on length of stay.

  1991cited by this paper
• Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).

  1991cited by this paper
• Electroconvulsive therapy in delusional and non-delusional depressive disorder.

  1990cited by this paper
• Perphenazine in the Treatment of Psychotic Depression

  1990cited by this paper
• Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.

  1990cited by this paper
• An atypical responder to clozapine.

  1990cited by this paper
• The Impact of Medication Resistance and Continuation Pharmacotherapy on Relapse following Response to Electroconvulsive Therapy in Major Depression

  1990cited by this paper
• Affective syndromes, psychotic features, and prognosis. I. Depression.

  1990cited by this paper
• Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.

  1989cited by this paper
• Relapse in delusional depression: a retrospective study of the course of treatment.

  1988cited by this paper
• Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman.

  1988cited by this paper
• The Roles of Glucocorticoid and Dopaminergic Systems in Delusional (Psychotic) Depression a

  1988cited by this paper
• Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course.

  1988cited by this paper
• Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables.

  1988cited by this paper
• Plasma catecholamine metabolites in subtypes of major depression.

  1987cited by this paper
• Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures.

  1987cited by this paper
• Urinary free cortisol in psychotic depression.

  1987cited by this paper
• Continuation Therapy After ECT for Delusional Depression: A Naturalistic Study of Prophylactic Treatments and Relapse.

  1987cited by this paper
• Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.

  1987cited by this paper
• The importance of psychotic features to major depression: course and outcome during a 2‐year follow‐up

  1987cited by this paper
• Electroencephalographic sleep in psychotic depression. A valid subtype?

  1986cited by this paper
• Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression.

  1986cited by this paper
• Outcome at Discharge and Six Months in Major Depression: The Significance of Psychotic Features

  1986cited by this paper
• Lithium augmentation in psychotic depression refractory to combined drug treatment.

  1986cited by this paper
• Demographic, Historical, and Symptomatic Features of the Nonmanic Psychoses

  1986cited by this paper
• Late-life delusional depression.

  1986cited by this paper
• The Prognosis of Depression in Old Age

  1986cited by this paper
• Delusional depression: phenomenology and response to treatment

  1986cited by this paper
• Delusional depression, family history, and DST response: a pilot study.

  1986cited by this paper
• Delusional depression. A one year follow-up.

  1985cited by this paper
• The pharmacological treatment of delusional depression.

  1985cited by this paper
• Relative Efficacy Rates for Therapies of Delusional Depression.

  1985cited by this paper
• Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

  1985cited by this paper
• Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression.

  1985cited by this paper
• Delusional Depression and Electroconvulsive Therapy: One Year Later.

  1985cited by this paper
• Delusional depression: a review of the literature and current perspectives

  1985cited by this paper

• Differentiation between psychotic and non-psychotic major depression by the tabular prior-data fitted network.

  2026cites this paper
• A reevaluation of mixed depressive states from the DSM-5- TR perspective: a series of prototypical cases.

  2024cites this paper
• Guidelines for the management of psychosis in the context of mood disorders.

  2022cites this paper
• Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression

  2020cites this paper
• Preventing Suicide among Psychiatric Inpatients with Psychotic Depression

  2019cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression.

  2019cites this paper
• Stabilization treatment of remitted psychotic depression: the STOP‐PD study

  2018cites this paper
• Clinical validation of the Psychotic Depression Assessment Scale (PDAS) against independent global severity ratings in older adults

  2018cites this paper
• Psychotic Depression and Suicidal Behavior

  2017cites this paper
• The best drug treatment for psychotic depression: Antidepressants, antipsychotics or both combined? Commentary On… Cochrane Corner

  2017cites this paper
• Systematic analysis of transdiagnostic epidemiology and clinical correlates of duration of untreated psychosis in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS)

  2017influential citation
• Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression

  2017cites this paper
• Is major depressive disorder with psychotic features more likely in elderly than adulthood

  2015cites this paper
• Cognitive markers of psychotic unipolar depression: a meta-analytic study.

  2015influential citation
• Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders.

  2014cites this paper
• Türkiye'de Bipolar Bozukluk Bipolar Disorder in Turkey

  2014cites this paper
• Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD ΙΙ

  2013cites this paper
• Symptom Profile and Severity in a Sample of Nigerians with Psychotic versus Nonpsychotic Major Depression

  2013influential citation
• Quest for Biomarkers of Treatment-Resistant Depression: Shifting the Paradigm Toward Risk

  2013cites this paper
• Does Comorbid Posttraumatic Stress Disorder Affect the Severity and Course of Psychotic Major Depression?

  2013cites this paper
• The Incidence of Tardive Dyskinesia in the Study of Pharmacotherapy for Psychotic Depression

  2013cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

  2013cites this paper
• Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression.

  2012cites this paper
• Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics

  2012cites this paper
• Treatment of auditory verbal hallucinations with transcranial magnetic stimulation in a patient with psychotic major depression: One-year follow-up

  2012cites this paper
• The hidden third: improving outcome in treatment-resistant depression

  2012cites this paper
• Meta-review of depressive subtyping models.

  2012cites this paper
• Guía de atención integral para la detección temprana y diagnóstico del episodio depresivo y trastorno depresivo recurrente en adultos. Atención integral de los adultos con diagnóstico de episodio depresivo o trastorno depresivo recurrente

  2012cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA Programa de Pós-Graduação em Ciências Médicas: Psiquiatria

  2012cites this paper
• [Actual problems of systematics of depression].

  2012cites this paper
• Yaşlı bir hastada ketiyapin ve EKT ile psikotik özellikli depresyonun etkili ve güvenli tedavisi

  2011influential citation
• Novel Therapeutic Approaches for Treating Bipolar Disorder

  2011cites this paper
• Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.

  2011cites this paper
• Transtorno Depressivo Maior (TDM) com e sem Sintomas Psicóticos: Investigação Neuroquímica por Espectroscopia de Próton

  2011cites this paper
• Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.

  2011cites this paper
• Combined Venlafaxine and Olanzapine Prescription in Women with Psychotic Major Depression: A Case Series

  2011cites this paper
• Lithium, but Not Fluoxetine or the Corticotropin-Releasing Factor Receptor 1 Receptor Antagonist R121919, Increases Cell Proliferation in the Adult Dentate Gyrus

  2011cites this paper
• Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era

  2010influential citation
• The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments

  2010cites this paper
• Does comorbid posttraumatic stress disorder affect the severity and course of psychotic major depressive disorder?

  2010cites this paper
• Psychoticism and Paranoid Ideation in Patients With Nonpsychotic Major Depressive Disorder: Prevalence, Response to Treatment, and Impact on Short- and Long-Term Treatment Outcome

  2010cites this paper
• Quetiapine: novel uses in the treatment of depressive and anxiety disorders

  2010cites this paper
• Novel Therapeutic Strategies for Bipolar Disorder

  2010cites this paper
• Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.

  2010cites this paper
• Potential novel treatments for bipolar depression

  2009cites this paper
• Dépressions sévères : traitements pharmacologiques Severe depression : pharmacological treatments

  2009cites this paper
• Maintenance pharmacotherapy for unipolar depression: focus on efficacy

  2009cites this paper
• Putative Drugs and Targets for Bipolar Disorder

  2009cites this paper
• Introduction and Clinical Presentations

  2009cites this paper
• [Severe depression : pharmacological treatments].

  2009cites this paper
• Does the Dexamethasone Suppression Test Reliably Discriminate Between Psychotic and Nonpsychotic Major Depression?: An Exploratory Analysis of Potential Confounds

  2009cites this paper
• Pharmacologic and therapeutic strategies in treatment-resistant depression. Introduction and clinical presentations.

  2009cites this paper
• Prevalence and clinical characteristics of psychotic versus nonpsychotic major depression in a general psychiatric outpatient clinic

  2009cites this paper
• First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.

  2008cites this paper
• Depressive symptom profiles and severity patterns in outpatients with psychotic vs nonpsychotic major depression.

  2008cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Psychotic Depression

  2008cites this paper
• Augmentation of Antidepressants with Atypical Antipsychotics: A Review of the Current Literature

  2008cites this paper
• Bipolar disorder: candidate drug targets.

  2008cites this paper
• Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.

  2008cites this paper
• Current trends in the assessment and somatic treatment of resistant/refractory major depression: An overview

  2008cites this paper
• Biologische behandlung unipolarer depressiver störungen in der allgemeinärztlichen versorgung: Leitlinien der World Federation of Societies of Biological Psychiatry (WFSBP)

  2008cites this paper
• Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.

  2007cites this paper
• Current issues in the classification of psychotic major depression.

  2007cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

  2007cites this paper
• Insomnia: pathophysiology and implications for treatment.

  2007cites this paper
• Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders

  2007cites this paper
• Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

  2007cites this paper
• Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

  2006cites this paper
• Current and emerging somatic treatment strategies in psychotic major depression

  2006cites this paper
• Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations.

  2006cites this paper
• Cortisol circadian rhythm alterations in psychotic major depression.

  2006cites this paper
• Psychotic Major Depression

  2006cites this paper
• Treatments in depression

  2006cites this paper
• Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities

  2006cites this paper
• Detecting psychotic major depression using psychiatric rating scales.

  2006cites this paper
• Risperidone in the treatment of psychotic depression.

  2006cites this paper
• Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.

  2006cites this paper
• Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness

  2006cites this paper
• A 60-year-old woman who has felt sad for much of her life.

  2006cites this paper
• Placebo response in psychotic depression.

  2005cites this paper
• Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.

  2005cites this paper
• Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.

  2005cites this paper
• LENGTH OF STAY, ADMISSION TYPES, PSYCHIATRIC DIAGNOSES, AND THE IMPLICATIONS OF STIGMA IN AFRICAN AMERICANS IN THE NATIONWIDE INPATIENT SAMPLE

  2005influential citation
• Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child.

  2005cites this paper
• Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed

  2005cites this paper
• Chapter 4.4 - Glucocorticoid antagonists and depression

  2005cites this paper
• Die therapieresistente Depression

  2005cites this paper
• Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data

  2005cites this paper
• An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression.

  2005cites this paper
• Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

  2005cites this paper
• Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor – Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies

  2005cites this paper
• Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.

  2005cites this paper
• The pharmacological management of depression

  2005cites this paper
• Tratamiento de la depresión psicótica

  2004cites this paper
• Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

  2004cites this paper
• Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

  2004cites this paper
• Study of prevalence of depressive symptoms and study of suicide risk in students of Ribeirão Preto , Brazil , assessed by the CDI

  2004cites this paper
• Depression in the elderly: new concepts and therapeutic approaches

  2004cites this paper
• Depresión psicótica: la utilización del algoritmo aumenta las probabilidades

  2004cites this paper
• Regulation of affect by the lateral septum: implications for neuropsychiatry.

  2004cites this paper